Results from a recent study suggested that polymorphisms within the HLA class II genes LMP2 and LMP7 were associated with the susceptibility for developing IDDM, and that this association could not be explained by linkage disequilibrium to HLA-DR or -DQ genes. We typed 285 IDDM patients and 337 HLA-DRB1-DQA1-DQB1 genotypically matched control subjects from an ethnically homogeneous population for both the G/T polymorphism in intron 6 of the LMP7 gene and the Arg-His polymorphism in the LMP2 gene. In addition, we typed IDDM families in which at least one parent was homozygous for a DRB1-DQA1-DQB1 haplotype and performed a transmission/disequilibrium test of these LMP polymorphisms. Our data suggest that none of these LMP2 or LMP7 polymorphisms are independently associated with IDDM susceptibility, in contrast to what has been previously reported by others. Further, our results suggest that one partial explanation for the previously reported independent association between IDDM and these LMP polymorphisms may have been that patients and control subjects were not matched for DRB1*04 subtypes. Our results emphasize the need for a complete matching for DRB1, DQA1, and DQB1 alleles between patients and control subjects when attempting to detect independent effects of other polymorphisms in the HLA complex on IDDM susceptibility or protection.
Skip Nav Destination
Article navigation
Original Articles|
February 01 1997
No Independent Associations of LMP2 and LMP7 Polymorphisms With Susceptibility to Develop IDDM
Dag E Undlien;
Dag E Undlien
Institute of Transplantation Immunology, The National Hospital
Oslo
Search for other works by this author on:
Hanne E Akselsen;
Hanne E Akselsen
Institute of Transplantation Immunology, The National Hospital
Oslo
Search for other works by this author on:
Geir Joner;
Geir Joner
Aker Diabetes Research Center, Aker University Hospital
Oslo
Search for other works by this author on:
Knut Dahl-Jørgensen;
Knut Dahl-Jørgensen
Aker Diabetes Research Center, Aker University Hospital
Oslo
Search for other works by this author on:
Oddmund Søvik;
Oddmund Søvik
Department of Pediatrics, University of Bergen
Bergen, Norway
Search for other works by this author on:
Kjersti S Rønningen;
Kjersti S Rønningen
Institute of Transplantation Immunology, The National Hospital
Oslo
Department of Population Health Sciences, National Institute of Public Health
Oslo
Search for other works by this author on:
Erik Thorsby
Erik Thorsby
Institute of Transplantation Immunology, The National Hospital
Oslo
Search for other works by this author on:
Address correspondence and reprint requests to Dag E. Undlien, Institute of Transplantation Immunology, The National Hospital, 0027 Oslo, Norway. E-mail: [email protected].
1
LMP genes, large multifunctional proteasomes genes; nc, not corrected; PCR, polymerase chain reaction; PCR-RFLP, polymerase chain reaction–restriction fragment length polymorphism; TAP, transporter associated with antigen processing; TDT, transmission/disequilibrium test.
Diabetes 1997;46(2):307–312
Article history
Received:
June 17 1996
Revision Received:
September 11 1996
Accepted:
September 11 1996
PubMed:
9000709
Citation
Dag E Undlien, Hanne E Akselsen, Geir Joner, Knut Dahl-Jørgensen, Oddmund Søvik, Kjersti S Rønningen, Erik Thorsby; No Independent Associations of LMP2 and LMP7 Polymorphisms With Susceptibility to Develop IDDM. Diabetes 1 February 1997; 46 (2): 307–312. https://doi.org/10.2337/diab.46.2.307
Download citation file:
59
Views